We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pheromone Trap Won’t Let the Bedbugs Bite

By HospiMedica International staff writers
Posted on 07 Jan 2015
A new study has uncovered the bedbug (Cimex lectularius) aggregation pheromone, laying the foundation for traps that could lure them to their death. More...


Researchers at Simon Fraser University (Burnaby, BC, Canada) used nuclear magnetic resonance (NMR) spectrometers to study the infinitesimal amounts of chemicals shed from human skin, looking for the chemical clues as to why the bedbugs find it so appealing. After two years of frustrating false leads, they finally discovered that histamine, a molecule with unusual properties that eluded identification through traditional methods, signals "safe shelter" to bedbugs. Once in contact with the histamine, the bedbugs stay in place, independent of whether or not they recently fed on a human host.

But when the researchers set out to test the compounds in infested apartments, neither histamine alone nor in combination with other previously identified pheromone components effectively attracted and trapped the bedbugs. The researchers therefore began analyzing airborne volatile compounds from bedbug feces as an alternate source of the missing components. Five months and 35 experiments later, they found three new volatiles that had never before been reported in the context of bedbugs.

The final aggregation pheromone is comprised of five volatile components (dimethyl disulfide, dimethyl trisulfide, (E)-2-hexenal, (E)-2-octenal, 2-hexanone), which attract bed bugs to safe shelters, and one less-volatile component (histamine), which keeps them there. The blend of all six components was highly effective at luring both juvenile and adult bed bugs into traps, with or without recent blood meals. The study was published on December 21, 2014, in Angewandte Chemie.

“The biggest challenge in dealing with bedbugs is to detect the infestation at an early stage,” said lead author Prof. Regine Gries, PhD. “This trap will help landlords, tenants, and pest-control professionals determine whether premises have a bedbug problem, so that they can treat it quickly. It will also be useful for monitoring the treatment's effectiveness.”

Over the last two decades the common bedbug, once thought eradicated in industrialized countries, has reappeared as a global scourge, infesting not only low-income housing but also hotels, public venues such as stores, movie theatres, libraries, and even public transit. And while previously not considered a carrier of disease, it has recently been discovered they can transmit the pathogen that causes Chagas disease, which is prevalent in Central and South America.

Related Links:

Simon Fraser University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.